US2002002281A1PendingUtilityA1
Method of preparing amino carboxylic acids
Priority: Feb 13, 1997Filed: Jun 1, 2001Published: Jan 3, 2002
Est. expiryFeb 13, 2017(expired)· nominal 20-yr term from priority
Inventors:Todd J. JohnsonMichael K. SternDavid A. MorgensternMichael D. RogersYvette M. FobianJeffrey A. Levine
C07C 275/16C07F 9/3813C07D 251/04C07D 251/14C07C 227/00C07D 241/18C07C 231/08
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Novel compounds, N,N′-bis(phosphonomethyl)-N,N′-bis(hydroxycarbonylmethyl)urea and N,N,N′,N′-tetrakis(hydroxycarbonylmethyl)urea, suitable for use in preparing N-acyl aminocarboxylic acids that can be readily converted to N-(phosphonomethyl)glycine are provided. The compounds may be formed by the reaction of bis-(phosophonomethyl)urea or urea respectively with carbon monoxide and formaldehyde in the presence of a carboxymethylation catalyst precursor and solvent.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An acetamide equivalent compound selected from the group consisting of compounds having the formula:
wherein R 13 and R 14 are independently hydrogen, hydroxymethyl, alkyl, carboxymethyl, phosphonomethyl, or an ester or salt of carboxymethyl or phosphonomethyl; R 15, R 16 and R 17 are independently alkyl or —NR 3 R 4 ; and R 3 and R 4 are independently hydrogen, hydrocarbyl, or substituted hydrocarbyl.
2 . The compound of claim 1 wherein R 13 , R 14 R 15, R 16 and R 17 are independently methyl, ethyl or isopropyl.
3 . The acetamide equivalent compound of claim 1 , wherein R 15 and R 16 are methyl.
4 . The acetamide equivalent compound of claim 1 , wherein the acetamide equivalent compound has the formula:
5 . The acetamide equivalent compound of claim 4 , wherein R 15 and R 16 are methyl.
6 . The acetamide equivalent compound of claim 4 , wherein R 15 and R 16 are ethyl.
7 . The acetamide equivalent compound of claim 4 , wherein R 15 , R 16 , and R 17 are methyl.
8 . The acetamide equivalent compound of claim 4 , wherein R 15 , R 16 , and R 17 are ethyl.
9 . The acetamide equivalent compound of claim 1 , wherein the acetamide equivalent compound has the formula:
10 . The acetamide equivalent compound of claim 9 , wherein R 15 and R 16 are methyl.
11 . The acetamide equivalent compound of claim 9 , wherein R 13 , R 14 , R 15 and R 16 are methyl.
12 . The acetamide equivalent compound of claim 9 , wherein R 13 , R 14 , R 15 , and R 16 are ethyl.
13 . The acetamide equivalent compound of claim 9 , wherein R 13 and R 14 are hydrogen; and R 15 and R 16 are methyl.
14 . The acetamide equivalent compound of claim 9 , wherein R 13 and R 14 are hydrogen; and R 15 and R 16 are ethyl.
15 . A compound having the formula:
wherein R 1 is hydrogen, hydrocarbyl, substituted hydrocarbyl, —NR 3 R 4 , or —SR 6 ;
R 3 and R 4 are independently hydrogen, hydrocarbyl, or substituted hydrocarbyl; and
R 6 is hydrogen, hydrocarbyl, substituted hydrocarbyl, or a salt-forming cation.
16 . The compound as set forth in claim 15 , wherein R 1 is methyl.
17 . The compound as set forth in claim 93 , wherein R 1 is —NR 3 R 4 .Join the waitlist — get patent alerts
Track US2002002281A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.